Senior insider sale
Chief Development Officer at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$1.55M
51K shares
What this filing means
MYLES DAVID C. plans to sell 51K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $1.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/19/2025ACC: 0001959173-25-007866
Officer· Chief Development Officer
Since Nov 2020
51K
Shares to sell
$1.55M
Approx. market value
51K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Restricted Stock Vesting
Compensation
12/10/2024
10.76KRestricted Stock Vesting
Compensation
12/9/2024
11.92KRestricted Stock Vesting
Compensation
11/21/2023
6.47KRestricted Stock Vesting
Compensation
11/20/2023
6.15KRestricted Stock Vesting
Compensation
6/15/2020
15.70KTotal acquired51K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/10/2024 | Restricted Stock Vesting Compensation | 10.76K | — |
12/9/2024 | Restricted Stock Vesting Compensation | 11.92K | — |
11/21/2023 | Restricted Stock Vesting Compensation | 6.47K | — |
11/20/2023 | Restricted Stock Vesting Compensation | 6.15K | — |
6/15/2020 | Restricted Stock Vesting Compensation | 15.70K | — |
| Total | 51K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
51K
Market value
$1.55M
12/19/2025
Total
Units
51K
Value
$1.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/19/2025 | 51K | $1.55M | NASDAQ | Planned |
| Total | 51K | $1.55M | ||